Dr. Alexa B. Kimball is CEO and president of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, a $670 million academic multispecialty 501(c)3 corporation with 2,000 employees. The group employs 1,750 physicians who practice in the Boston area, two-thirds of whom are Harvard Medical School faculty. She co-chairs the Beth Israel Lahey Health Performance Network board (1.3 million members served), and is on the board of trustees of Beth Israel Lahey Health.
A professor of dermatology at Harvard Medical School, Dr. Kimball’s research includes psoriasis and hidradenitis suppurativa. She has published over 300 papers, conducted over 150 clinical trials, and has extensive experience in drug development. Dr. Kimball is the author of "100 Questions and Answers about Psoriasis" (available in Spanish, Greek, and Korean) and "Hidradenitis Suppurativa: Your Questions, Expert Answers," and the editor of “Dermatologic Diseases and Cumulative Life Course Impairment.”
In recognition of her research on physician workforce economics, quality of life, and outcomes, she was awarded the American Skin Association Research Award for Health Policy and Medical Education and the Massachusetts General Hospital Nathaniel Bowditch Prize. Other awards include Mentor of the Year and an Outstanding Physician-Clinician Award. Dr. Kimball has served on the nonprofit boards of the Society for Investigative Dermatology, the Massachusetts Foundation for the Humanities and Public Policy, and the Hidradenitis Suppurativa Foundation. She is the recent past president of the International Psoriasis Council.